A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

A Dividend and Dynamite approach pairs ultra‐yielding blue chips with top‐tier growth stocks. Click here to read more about ...

Australian stocks are soaring as the first interest rate cut looms but value is far from universal as the market nears record ...

The Federal Reserve decided to delay additional rate cuts for now and keep interest rates unchanged at its first meeting of ...

US stocks faced a decline on Wednesday after the Federal Reserve decided to leave interest rates unchanged, signaling a ...

The Federal Reserve held interest rates steady Wednesday as policymakers weigh the direction of inflation and the potential ...

Stock traders took some risk off the table before the Federal Reserve decision, with a trio of tech heavyweights kicking off ...